Regulatory status: IVD, FDA Class I
60-0113-7 7mL RTU
This antibody labels laminin, which is present in the basement membrane. The antibody may be useful in the characterization of basement membrane preservation, e.g. in breast cancer and adenocarcinomas of the lung when used in a panel of antibodies. Laminins have been found to promote cell adhesion, migration, protease activity, proliferation, tumor growth, angiogenesis and metastasis.